|
| 35906838 | Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe Coronavirus Disease 2019: The PANCOVID Randomized Clinical Trial. | Clin Infect Dis | 2023 |
| 37725999 | Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens. | J Antimicrob Chemother | 2023 |
| 37024277 | TRPC6 inhibitor (BI 764198) to reduce risk and severity of ARDS due to COVID-19: a phase II randomised controlled trial. | Thorax | 2023 |
| 37454762 | Clinical outcomes by supplemental oxygen use in remdesivir-treated, hospitalised adults with COVID-19. | Infect Dis Now | 2023 |
| 36909731 | Plitidepsin in adult patients with COVID-19 requiring hospital admission: A long-term follow-up analysis. | Front Cell Infect Microbiol | 2023 |
| 36769511 | Use of Monoclonal Antibodies in Immunocompromised Patients Hospitalized with Severe COVID-19: A Retrospective Multicenter Cohort. | J Clin Med | 2023 |
| 36639241 | Faster lung function decline in people living with HIV despite adequate treatment: a longitudinal matched cohort study. | Thorax | 2023 |
| 34600119 | Predictors of poor prognosis in healthy, young, individuals with SARS-CoV-2 infections. | Clin Microbiol Infect | 2022 |
| 35802475 | Progress in the quality of care for newly diagnosed people with HIV in Spain (2004-2019). | Antivir Ther | 2022 |
| 35736525 | Efficiency of screening for human immunodeficiency virus infection in emergency departments: a systematic review and meta-analysis. | Emergencias | 2022 |
| 35399147 | Shorter Time to Discontinuation Due to Treatment Failure in People Living with HIV Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish Cohort. | Infect Dis Ther | 2022 |
| 35830908 | Monkeypox outbreak in Madrid (Spain): Clinical and virological aspects. | J Infect | 2022 |
| 35685504 | Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID-19: Insights from the HOPE COVID-19 Registry. | Int J Clin Pract | 2022 |
| 35355397 | Thalassaemia is paradoxically associated with a reduced risk of in-hospital complications and mortality in COVID-19: Data from an international registry. | J Cell Mol Med | 2022 |
| 35748016 | Interactions among the mycobiome, bacteriome, inflammation, and diet in people living with HIV. | Gut Microbes | 2022 |
| 36109825 | Effect of EARLY administration of DEXamethasone in patients with COVID-19 pneumonia without acute hypoxemic respiratory failure and risk of development of acute respiratory distress syndrome (EARLY-DEX COVID-19): study protocol for a randomized controlled trial. | Trials | 2022 |
| 35012962 | Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19. | Life Sci Alliance | 2022 |
| 35124787 | Epidemiologic and Economic Analysis of Rapid Antiretroviral Therapy Initiation with Bictegravir/Emtricitabine/Tenofovir Alafenamide in Spain. | Pharmacoecon Open | 2022 |
| 34756571 | Predicting COVID-19 progress with clinical scales. | Rev Clin Esp (Barc) | 2022 |
| 34483348 | [Predicting COVID-19 progress with clinical scales]. | Rev Clin Esp | 2022 |
| 32601702 | Blood Bacterial Profiles Associated With Human Immunodeficiency Virus Infection and Immune Recovery. | J Infect Dis | 2021 |
| 33741308 | Does there exist an obesity paradox in COVID-19? Insights of the international HOPE-COVID-19-registry. | Obes Res Clin Pract | 2021 |
| 33678938 | [Atrial fibrillation in patients with COVID-19. Usefulness of the CHA<sub>2</sub>DS<sub>2</sub>-VASc score: an analysis of the international HOPE COVID-19 registry]. | Rev Esp Cardiol | 2021 |
| 33646505 | COVID-19 anosmia and gustatory symptoms as a prognosis factor: a subanalysis of the HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry. | Infection | 2021 |
| 33539363 | Low use of condom and high STI incidence among men who have sex with men in PrEP programs. | PLoS One | 2021 |
| 33845032 | Renin-angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: Final analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry. | Am Heart J | 2021 |
| 33813554 | Late presentation for HIV impairs immunological but not virological response to antiretroviral treatment. | AIDS | 2021 |
| 33918840 | Serological Tests in the Detection of SARS-CoV-2 Antibodies. | Diagnostics (Basel) | 2021 |
| 33727235 | Non-invasive ventilation for SARS-CoV-2 acute respiratory failure: a subanalysis from the HOPE COVID-19 registry. | Emerg Med J | 2021 |
| 33583755 | Atrial fibrillation in patients with COVID-19. Usefulness of the CHA<sub>2</sub>DS<sub>2</sub>-VASc score: an analysis of the international HOPE COVID-19 registry. | Rev Esp Cardiol (Engl Ed) | 2021 |
| 33861553 | Anticoagulation Therapy in Patients With Coronavirus Disease 2019: Results From a Multicenter International Prospective Registry (Health Outcome Predictive Evaluation for Corona Virus Disease 2019 [HOPE-COVID19]). | Crit Care Med | 2021 |
| 33555436 | Clinical presentation, therapeutic approach, and outcome of young patients admitted for COVID-19, with respect to the elderly counterpart. | Clin Exp Med | 2021 |
| 33831047 | Real world effectiveness of standard of care triple therapy versus two-drug combinations for treatment of people living with HIV. | PLoS One | 2021 |
| 33721153 | Personalized prescription of ACEI/ARBs for hypertensive COVID-19 patients. | Health Care Manag Sci | 2021 |
| 34913844 | Impact of treatment adherence on efficacy of dolutegravir plus lamivudine and dolutegravir plus tenofovir disoproxil fumarate/emtricitabine: pooled analysis of the GEMINI-1 and GEMINI-2 clinical studies. | HIV Res Clin Pract | 2021 |
| 35237700 | Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57). | Open Forum Infect Dis | 2021 |
| 34823642 | Changes in the profile of newly HIV-diagnosed men who have sex with men, Madrid, 2014 to 2019. | Euro Surveill | 2021 |
| 34410219 | eGFR-EPI changes among HIV patients who switch from F/TDF to F/TAF while maintaining the same third agent in the Spanish VACH cohort. | HIV Res Clin Pract | 2021 |
| 34409593 | COVID-19 and the impact of arterial hypertension-An analysis of the international HOPE COVID-19 Registry (Italy-Spain-Germany). | Eur J Clin Invest | 2021 |
| 34706286 | In-vivo evidence of systemic endothelial vascular dysfunction in COVID-19. | Int J Cardiol | 2021 |
| 34632069 | Prognostic factors at admission on patients with cancer and COVID-19: Analysis of HOPE registry data. | Med Clin (Engl Ed) | 2021 |
| 34629634 | Prevalence and 30-Day Mortality in Hospitalized Patients With Covid-19 and Prior Lung Diseases. | Arch Bronconeumol | 2021 |
| 34805199 | Sepsis of Patients Infected by SARS-CoV-2: Real-World Experience From the International HOPE-COVID-19-Registry and Validation of HOPE Sepsis Score. | Front Med (Lausanne) | 2021 |
| 34749645 | Inadequate use of antibiotics in the covid-19 era: effectiveness of antibiotic therapy. | BMC Infect Dis | 2021 |
| 34834438 | Standardized Comparison of Cardiovascular Risk Factors Prevalence in Spanish Women and Men Living with HIV and in the General Population. | J Pers Med | 2021 |
| 34129486 | Gender Differences in the Presentation and Outcomes of Hospitalized Patients With COVID-19. | J Hosp Med | 2021 |
| 34075384 | Plitidepsin has a positive therapeutic index in adult patients with COVID-19 requiring hospitalization. | medRxiv | 2021 |
| 34154809 | Prognostic factors at admission on patients with cancer and COVID-19: Analysis of HOPE registry data. | Med Clin (Barc) | 2021 |
| 34308137 | Impact of smoking on COVID-19 outcomes: a HOPE Registry subanalysis. | BMJ Nutr Prev Health | 2021 |
| 34134131 | Cardiovascular Risk and Health Among People With Human Immunodeficiency Virus (HIV) Eligible for Primary Prevention: Insights From the REPRIEVE Trial. | Clin Infect Dis | 2021 |